Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • State News

    State News - Page 7

    Bribery for passing failed Dobutamine Injections: Pharma Company Owner, CDSCO drug inspector Arrested

    Bribery for passing failed Dobutamine Injections: Pharma Company Owner, CDSCO drug inspector Arrested

    Farhat Nasim17 Aug 2019 3:02 PM IST
    As per recent media accounts, the CDSCO inspector allegedly demanded a bribe of Rs 1.5 lakh in lieu of overlooking the deficits and approving a...
    Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia

    Wish to see India excel in pharmaceutical research, says Delhi Deputy CM Manish Sisodia

    Medical Dialogues Bureau15 Aug 2019 9:50 AM IST
    Addressing students of the Delhi Pharmaceutical Sciences and Research University (DPSRU), Pushp Vihar, here, Manish Sisodia said that India is placed...
    Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

    Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

    Medical Dialogues Bureau15 Aug 2019 9:30 AM IST
    The combined synergies of Narayana Health as a knowledge partner, Syngene and Biocon Foundation as funding partners and Agastya International as the...
    Indian pharma industry may achieve double-digit growth by 2030 via regulatory support from Government, says pharma industry body

    Indian pharma industry may achieve double-digit growth by 2030 via regulatory support from Government, says pharma industry body

    Medical Dialogues Bureau15 Aug 2019 9:25 AM IST
    "Ayushman Bharat Scheme that brings 40 per cent of the poor population under state-funded insurance cover also broadens possibilities to all...
    2 dead, 1 injured after fire engulfed Aurobindo Pharma power plant in Andhra Pradesh

    2 dead, 1 injured after fire engulfed Aurobindo Pharma power plant in Andhra Pradesh

    Farhat Nasim13 Aug 2019 6:16 PM IST
    Srikakulam: In an unfortunate incident, a couple of contractual workers died due to a blast in the boiler unit of Aurobindo Pharmaceuticals (Aurobindo...
    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Medical Dialogues Bureau13 Aug 2019 1:16 PM IST
    Natco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
    Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni

    Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni

    Medical Dialogues Bureau12 Aug 2019 12:26 PM IST
    New Delhi: Natco Pharma is focusing on filing of cancer treatment drugs in China, the world's second largest pharmaceutical market, as part of its...
    Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

    Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

    Medical Dialogues Bureau11 Aug 2019 9:47 AM IST
    Justice Sunil Gaur said the accused deserve bail on merits and the orders granting them relief is not liable to be interfered with as the impugned...
    USFDA completes inspection of Nagpur facility with no observations: Lupin

    USFDA completes inspection of Nagpur facility with no observations: Lupin

    Medical Dialogues Bureau10 Aug 2019 9:30 AM IST
    The inspection by the US Food and Drug Administration (USFDA) for a facility at Nagpur was carried out between August 5, 2019, and August 8, 2019. It...
    Chemcon Speciality Chemicals files Rs 350 crore IPO papers with SEBI

    Chemcon Speciality Chemicals files Rs 350 crore IPO papers with SEBI

    Medical Dialogues Bureau10 Aug 2019 9:30 AM IST
    The key customers of the company's pharmaceutical chemicals include Hetero Labs, Laurus Labs, Aurobindo Pharma and IndSwift Laboratories. The shares...
    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Farhat Nasim8 Aug 2019 9:00 AM IST
    Puneet Srivastava will lead the Sales and Marketing function at a group level. Prior to joining Paras Healthcare, Srivastava was associated with the...
    Natco Pharma gets EIR from USFDA for Kothur facility

    Natco Pharma gets EIR from USFDA for Kothur facility

    Medical Dialogues Bureau6 Aug 2019 4:35 PM IST
    New Delhi: Drug firm Natco Pharma on Monday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
    PrevNext

    Popular Stories

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok